Home Biometrics - DNA Direct, Inc

By: Wc Music Research  09-12-2011
Keywords: Healthcare Costs


Individuals with Diabetes

  • Lack of patient testing and awareness of A1C and lipid levels
  • Lack of awareness of ideal ranges for A1C and lipid levels
  • Higher health costs for those with diabetes, especially those undiagnosed
  • Clinical challenges: Diabetes increases the risk for many serious health problems.

Individuals At-Risk for Diabetes

  • Poor understanding of risk factors associated with diabetes
  • Lack of A1C test understanding and awareness
  • Potential for health complications associated with diabetes


Individuals with Diabetes

  • Utilizes at-home tests to engage members diagnosed with or at risk for chronic cardiac conditions to take a more active role in improving and managing their diabetes
  • Drives awareness of optimal A1C and lipid values while coordinating therapy and care through Medco Therapeutic Resource Centers (TRC)
  • Testing in accordance with American Diabetes Association guidelines
  • Empowers patients with actionable reporting of test results
  • Specialist pharmacist outreach and counseling for patients with “at-risk” results

 Individuals At-Risk for Diabetes

  • Utilizes at-home tests to engage members at-risk for developing diabetes
  • Educate and increase awareness of optimal A1C values
  • Early intervention for those at-risk for diabetes to reverse and prevent diabetes progression while coordinating therapy and care through Medco TRC


Individuals with Diabetes

  • Educate and promote treatment for individuals with diabetes who are not meeting American Diabetes Association (ADA) targets
  • Enhance clinical outcomes through improved adherence to diabetes medications
  • Lower overall healthcare costs
  • Provides members with reporting and tools to help engage their physician regarding their diabetes

Individuals At-Risk for Diabetes

  • Integrates with existing diabetes initiatives
  • Reduce the number of members who have diabetes and are not aware of it.
  • Help individuals at-risk for diabetes understand the steps necessary to improve their health and avoid the progression to diabetes.
  • Early treatment of individuals at-risk for diabetes may slow diabetes progression and avoid adverse events or complications. 
  • Lower overall healthcare costs
  • Provides members with reporting and tools to help engage their physician regarding their health 

Keywords: Healthcare Costs

Contact Wc Music Research


Print this page

Other products and services from Wc Music Research


Genomic Medicine Network - DNA Direct, Inc

The GMN provides information and interactive decision support tools for over 50 genetic testing areas, representing specialties such as reproductive planning, oncology, infectious disease, drug response, and others. The DNA Direct Genomic Medicine Network enables cost-effective integration of genomic medicine into clinical care by offering hospitals and medical centers.


Clinical Testing Programs - DNA Direct, Inc

Difficulty keeping up with the advances in pharmacogenomics that can help doctors more accurately predict who will respond to which drug and what their optimal dose would be. Improves health outcomes and savings by reducing unnecessary drug expenditures and avoiding potential healthcare costs. Identifies potential for adverse drug events based on genetic or biomarker information.


Decision Support Program - DNA Direct, Inc

Web- and phone-based educational resource that helps members to make more informed decisions, identify gene-related risks, and understand when and why genetic testing is indicated. Pre- and post-test decision support and genetic counseling educates members about available testing and results interpretation. Media coverage and advertising is creating interest, but a lack of expertise limits appropriate adoption.